Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Meiss

Showing results (61-70 of 110) with videos related to

Pageof 11
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 3, 2025
Real-world management of patients with complete response under immune-checkpoint inhibition for advanced melanomaMarkus Reitmajer, Elisabeth Livingstone, Kai-Martin Thoms, et al.
International Journal of Environmental Research and Public Health|July 27, 2022
eHealth Literacy in German Skin Cancer PatientsHenner Stege, Sara Schneider, Andrea Forschner, et al.
Cancers|January 26, 2024
Epidermolysis-Bullosa-Associated Squamous Cell Carcinomas Support an Immunosuppressive Tumor Microenvironment: Prospects for ImmunotherapyDavid Rafei-Shamsabadi, Lena Scholten, Sisi Lu, et al.
Cancer Research|November 15, 2018
miR-146a Controls Immune Response in the Melanoma MicroenvironmentJustin Mastroianni, Natalie Stickel, Hana Andrlova, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2016
Use of complementary and alternative medicine: A multicenter cross-sectional study in 1089 melanoma patientsCarmen Loquai, Dagmar Dechent, Marlene Garzarolli, et al.
Melanoma Research|March 3, 2017
Interactions from complementary and alternative medicine in patients with melanomaCarmen Loquai, Irene Schmidtmann, Marlene Garzarolli, et al.
Medical Oncology (Northwood, London, England)|April 20, 2016
Risk of interactions between complementary and alternative medicine and medication for comorbidities in patients with melanomaCarmen Loquai, Dagmar Dechent, Marlene Garzarolli, et al.
Cancer Immunology, Immunotherapy : CII|March 1, 2018
Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disordersKatharina C Kähler, Thomas K Eigentler, Anja Gesierich, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 23, 2017
Targeting of Cell Surface Proteolysis of Collagen XVII Impedes Squamous Cell Carcinoma ProgressionCélimène Galiger, Stefanie Löffek, Marc P Stemmler, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 12, 2024
Second opinion and self-efficacy in German skin cancer patientsHenner Stege, Sara Schneider, Andrea Forschner, et al.
Pageof 11

Showing results (61-70 of 110) with videos related to

Sort By:
Pageof 11
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 3, 2025
Real-world management of patients with complete response under immune-checkpoint inhibition for advanced melanomaMarkus Reitmajer, Elisabeth Livingstone, Kai-Martin Thoms, et al.
International Journal of Environmental Research and Public Health|July 27, 2022
eHealth Literacy in German Skin Cancer PatientsHenner Stege, Sara Schneider, Andrea Forschner, et al.
Cancers|January 26, 2024
Epidermolysis-Bullosa-Associated Squamous Cell Carcinomas Support an Immunosuppressive Tumor Microenvironment: Prospects for ImmunotherapyDavid Rafei-Shamsabadi, Lena Scholten, Sisi Lu, et al.
Cancer Research|November 15, 2018
miR-146a Controls Immune Response in the Melanoma MicroenvironmentJustin Mastroianni, Natalie Stickel, Hana Andrlova, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2016
Use of complementary and alternative medicine: A multicenter cross-sectional study in 1089 melanoma patientsCarmen Loquai, Dagmar Dechent, Marlene Garzarolli, et al.
Melanoma Research|March 3, 2017
Interactions from complementary and alternative medicine in patients with melanomaCarmen Loquai, Irene Schmidtmann, Marlene Garzarolli, et al.
Medical Oncology (Northwood, London, England)|April 20, 2016
Risk of interactions between complementary and alternative medicine and medication for comorbidities in patients with melanomaCarmen Loquai, Dagmar Dechent, Marlene Garzarolli, et al.
Cancer Immunology, Immunotherapy : CII|March 1, 2018
Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disordersKatharina C Kähler, Thomas K Eigentler, Anja Gesierich, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 23, 2017
Targeting of Cell Surface Proteolysis of Collagen XVII Impedes Squamous Cell Carcinoma ProgressionCélimène Galiger, Stefanie Löffek, Marc P Stemmler, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 12, 2024
Second opinion and self-efficacy in German skin cancer patientsHenner Stege, Sara Schneider, Andrea Forschner, et al.
Pageof 11